Recently suggested AD diagnoses are brain positron emission tomography (PET) scans, which can detect amyloid and tau depositions, and cerebrospinal fluid (CSF) analysis, which can detect candidates for pathological proteins [7]. Here, MAPT is linked to Alzheimer disease.